Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07MGN
|
||||
Former ID |
DNC007104
|
||||
Drug Name |
NSC-224124
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528457] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H12N2O8
|
||||
Canonical SMILES |
C1=CC(=O)C2=C(C1=O)C(=C(C(=C2O)COC(=O)N)COC(=O)N)O
|
||||
InChI |
1S/C14H12N2O8/c15-13(21)23-3-5-6(4-24-14(16)22)12(20)10-8(18)2-1-7(17)9(10)11(5)19/h1-2,19-20H,3-4H2,(H2,15,21)(H2,16,22)
|
||||
InChIKey |
VCZBTSKVAAVCJJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | NAD(P)H dehydrogenase [quinone] 1 | Target Info | Inhibitor | [528457] | |
KEGG Pathway | Ubiquinone and other terpenoid-quinone biosynthesis | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
Pathway Interaction Database | Validated transcriptional targets of TAp63 isoforms | ||||
PathWhiz Pathway | Vitamin K Metabolism | ||||
WikiPathways | Estrogen metabolism | ||||
Oxidative Stress | |||||
Transcriptional activation by NRF2 | |||||
NRF2 pathway | |||||
Nuclear Receptors Meta-Pathway | |||||
Aryl Hydrocarbon Receptor Pathway | |||||
Apoptosis-related network due to altered Notch3 in ovarian cancer | |||||
Metabolism of amino acids and derivatives | |||||
Aryl Hydrocarbon Receptor | |||||
Dopamine metabolism | |||||
Arylhydrocarbon receptor (AhR) signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.